Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Status:
Completed
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized study to evaluate the efficacy and safety of ORACEA® in the
treatment of geographic atrophy due to dry age-related macular degeneration (AMD).